Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
11/2005
11/16/2005EP1450833A4 Anti-hsv agent for inhibiting replication of hsv-1 and hsv-2 and method of producing a substance having anti-hsv activity
11/16/2005EP1292319B1 Extracts from spermatophyte plants with antitumor activity
11/16/2005EP1061894B1 Fragrance enhancing compositions for cosmetic products
11/16/2005CN1697661A Methods of treating diabetes using PDE 11A inhibitors
11/16/2005CN1697645A Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin
11/16/2005CN1227354C Combination of lactic acid bacteria and its use for prevention and/or treatment of infections and inflammatory conditions
11/16/2005CN1227250C Process for preparing azacycloalkanoyl aminothiazoles
11/16/2005CN1227241C Arylpiperazines having activity at the serotnin 1A receptor
11/16/2005CN1227233C 5-chloro-3-(4-methane sulfonylphenyl)-6-methyl-[2,3'] bipyridine and process for synthesis
11/16/2005CN1227030C Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
11/16/2005CN1226991C Turmeric as antiirritant in composition contg. hydroxy acid or retinene derives.
11/15/2005US6964984 Preventing desensitization of receptors
11/15/2005US6964972 8-Azabicyclo(3,2,1)oct-2 ene and octane derivatives as cholinergic ligands at nicotinic ACh receptors
11/15/2005US6964871 Systems and methods for blood glucose sensing
11/15/2005US6964784 Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals
11/15/2005US6964780 Phosphodiesterase inhibitor; therapy for sexual disorders; sildenafil in polyoxyethylene glycol enteric coating
11/15/2005CA2296637C Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containingit
11/10/2005WO2005051327A3 Glycopegylated erythropoietin
11/10/2005WO2005046554A3 Altering the stiffness, size, and/or shape of tissues for breathing disorders and other conditions
11/10/2005WO2005034846A3 Withanamide and withanolide compositions and method of use thereof
11/10/2005WO2005032465A3 3,5-aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as s1p receptor agonists
11/10/2005WO2005030121A3 Compounds, compositions and methods
11/10/2005WO2005000216A3 Combination of an nmda receptor antagonist and a selective serotonin reuptake inhibitor for the treatment of depression and other mood disorders
11/10/2005WO2004112725A3 Methods for inhibiting or reversing tau filament fibrillization
11/10/2005WO2004105693A3 Components, systems and methods for forming anastomoses using magnetism or other coupling means
11/10/2005WO2004103284A3 Compositions of a benzenesulfonamide or methylsulfonylbenzene cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous system
11/10/2005WO2004082640A8 Human serum albumin conjugates with therapeutic compounds
11/10/2005WO2004082634A3 Facially amphiphilic polymers and oligomers and uses thereof
11/10/2005WO2004075842A3 Mrp3 genes and uses thereof
11/10/2005US20050250834 11-(Aminoalkyl)isoindolo[2,1-a]indol-6-ones: 11-(2-Dimethylaminoethyl)-2-fluoroisoindolo[2,1-a]indol-6-one; psychological disorders, drug abuse, sleep disorders, Alzheimer's, Parkinson's and Huntington's disease, Irritable bowel syndrome, chemotherapy induced emesis, spinal trauma and/or head injury
11/10/2005US20050250815 e.g. 4-Methoxy-pyrrolidine-1,2-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 2-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease
11/10/2005US20050250806 Nicotinic acetylcholine receptor antagonists in the treatment of restless legs syndrome
11/10/2005US20050250802 Novel substituted amines of spirofuropyridines useful in therapy
11/10/2005US20050250801 Method of treating cancer with azaspirane compositions
11/10/2005US20050250782 Heterocyclic inhibitors of MEK and methods of use thereof
11/10/2005US20050250774 N-{2-[2-(3,4-Dimethoxy-phenyl)-ethoxy]-6-morpholin-4-yl-pyridin-4-yl}-N'-(1 H-indol-3-ylmethylene)-hydrazine; interleukin IL-12 overproduction-related disorder; antiinflammatory agent; autoimmune diseases: multiple sclerosis, sepsis, neuropathies, cirrhosis, hepatitis, diabetes, arthritis
11/10/2005US20050250712 Single dose azithromycin
11/10/2005US20050250689 Antagonists for human prolactin
11/10/2005US20050250684 Method for reducing morbidity and mortality in critically ill patients
11/10/2005US20050250156 Detection of acute myocardial infarction biomarkers
11/10/2005US20050250105 Multiple viral replicon culture systems
11/10/2005US20050249831 Herbal extract comprising a mixture of saponins obtained from sapindus trifoliatus for anticonvulsant activity
11/10/2005US20050249697 Compositions and methods for the inhibition of bone growth and resorption
11/09/2005EP1593380A2 Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits
11/09/2005EP1592801A2 Tandem analyses of noncovalently driven effectors for modulatory mapping of activities of protein sites
11/09/2005EP1592796A2 Helminth-derived antigens having capacity of providing protection against parasites
11/09/2005EP1592787A2 TREATMENT OR PREVENTION OF cGMP-DEPENDENT PATHOPHYSIOLOGY WITH A MUTANT VARIANT OF SOLUBLE GUANYLYL CYCLASE
11/09/2005EP1592760A2 Solid dispersion compositions
11/09/2005EP1592665A2 Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
11/09/2005EP1592656A2 Medicinal compounds
11/09/2005EP1592464A2 Method of treating cognitive decline due to sleep deprivation and stress
11/09/2005EP1592457A2 Vitamin receptor binding drug delivery conjugates
11/09/2005EP1592455A2 Herpesvirus amplicon particles
11/09/2005EP1592440A2 Immunoglobulin formulation and method of preparation thereof
11/09/2005EP1592438A2 Night-time oral insulin therapy
11/09/2005EP1592437A2 Polymerized hemoglobin solutions having reduced amount of tetramer and method for preparing
11/09/2005EP1592432A2 Modified polysaccharides combination with anti-cancer drugs for enhanced treatment of cancer
11/09/2005EP1592430A2 Treatment of benign prostatic hyperplasia using energolytic agents
11/09/2005EP1592415A2 Therapeutically active compounds
11/09/2005EP1592392A2 Production of very long chain polyunsaturated fatty acids in oilseed plants
11/09/2005EP1592391A2 Tra16 a tr4/tr2 repressor
11/09/2005EP1592390A2 Enhanced bioavailability of nutrients, pharmaceutical agents, and other bioactive substances through laser resonant homogenization or modification of molecular shape or crystalline form
11/09/2005EP1592388A2 Methods for diagnosis anf monitoring of neurological disease by detection of an encephalotoxin
11/09/2005EP1592387A2 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents
11/09/2005EP1592386A2 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents
11/09/2005EP1592385A2 Lactate dehydrogenase as a novel target and reagent for diabetes therapy
11/09/2005EP1592384A2 Cop 1 for treatment of inflammatory bowel diseases
11/09/2005EP1592383A2 Methods for reducing mortality associated with acute myocardial infarction
11/09/2005EP1244419B1 Agent for dyeing keratin containing fibers
11/09/2005EP1202974B1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/09/2005EP1165576B1 Process for preparing amine platinum complexes
11/09/2005EP1019089B1 Long-acting drugs and pharmaceutical compositions comprising them
11/09/2005CN1694871A Imidazolopyridines and methods of making and using the same
11/09/2005CN1694870A Acetyl 2-hydroxy-1, 3-diaminoalkanes
11/09/2005CN1694723A Vaccine
11/08/2005US6963017 Reacting indanone compound with coupling component
11/08/2005US6962993 Useful as inhibitors of protein kinases, such as the enzyme Janus Kinase 3
11/08/2005US6962970 Glycopeptide derivatives and pharmaceutical compositions containing the same
11/08/2005CA2451684C Stable cosmetic emulsion with polyamide gelling agent
11/03/2005WO2005103071A1 Peptide inhibitors of metalloproteinase activity
11/03/2005WO2005102362A1 Use of chondroitin sulphate e (cs-e ) for the treatment diseases or conditions related to collagen fibril formation.
11/03/2005WO2005102287A2 Pharmaceutical compositions for acute glucocorticoid therapy
11/03/2005WO2005055957A3 Influenza immunogen and vaccine
11/03/2005WO2005055936A3 Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells
11/03/2005WO2005053608A8 Preparing for individualized dosage forms of medicaments
11/03/2005WO2005053607A3 Method for preventing hepatic encephalopathic episodes
11/03/2005WO2005051295A3 Asymmetrically branched polymer conjugates and microarray assays
11/03/2005WO2005046608A3 Novel compound, corresponding compositions, preparation and/or treatment methods
11/03/2005WO2005046597A3 Antibodies to cd44 glycoforms and uses thereof
11/03/2005WO2005044201A3 Ph sensitive prodrugs of 2,6-diisopropylphenol
11/03/2005WO2005037214A3 Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication
11/03/2005WO2005025511A3 Potassium channel mediated delivery of agents through the blood-brain barrier
11/03/2005WO2005020927A3 Method of promoting graft survival with anti-tissue factor antibodies
11/03/2005WO2005020892A3 Pharmaceutical compositions and methods for metabolic modulation
11/03/2005WO2005018569A3 Compositions of a cyclooxygenase-2 selective inhibitor and a serotonin modulating agent for the treatment of neoplasia
11/03/2005WO2005018546A3 Compositions for diabetes treatment and prophylaxis
11/03/2005WO2005016285A3 Compositions and methods for inhibiting slit protein and glypican interactions
11/03/2005WO2005011611A3 Bicyclic compounds and compositions as pdf inhibitors
11/03/2005WO2005009396A3 Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections
11/03/2005WO2005002518A3 Methods for treating and preventing cardiac arrhythmia
1 ... 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 ... 295